CC BY 4.0 · Rev Bras Ginecol Obstet 2019; 41(05): 291-297
DOI: 10.1055/s-0039-1688708
Original Article
Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

Knowledge of Pregnant Adolescents about Human Papillomavirus

Conhecimento de adolescentes gestantes sobre o papilomavírus humano
1   School of Nursing, Universidade Estadual de Campinas, Campinas, SP, Brazil
,
Sílvia Souza Kamizaki
1   School of Nursing, Universidade Estadual de Campinas, Campinas, SP, Brazil
,
Silvana Maria Quintana
2   Department of Gynecology and Obstetrics, School of Medicine, Universidade de São Paulo, Ribeirão Preto, SP, Brazil
,
Rodolfo de Carvalho Pacagnella
3   Department of Gynecology and Obstetrics, School of Medical Sciences, Universidade Estadual de Campinas, Campinas, SP, Brazil
,
Fernanda Garanhani Surita
3   Department of Gynecology and Obstetrics, School of Medical Sciences, Universidade Estadual de Campinas, Campinas, SP, Brazil
› Institutsangaben
Weitere Informationen

Publikationsverlauf

25. Mai 2018

04. April 2019

Publikationsdatum:
10. Juni 2019 (online)

Abstract

Objective To evaluate the level of information possessed by pregnant adolescents regarding the human papillomavirus (HPV).

Methods Descriptive study developed in the adolescent prenatal outpatient clinic of a tertiary hospital from the state of São Paulo, Brazil. Data were collected between June and December 2017 following approval from the ethics and research committee (CAAE: 1.887.892/2017). Pregnant adolescents, ≤18 years old, who attended the abovementioned outpatient section, composed the sample. Those diagnosed with a psychiatric disorder and those with hearing or cognitive disabilities were excluded. After acceptance to participate in the present study, the pregnant adolescents signed an Informed Consent Form. Regarding the statistical analysis, the chi-squared test and the Fisher exact test were used.

Results Regarding the knowledge about HPV, 123 (80.92%) of the participants had already heard about the subject; for 77 (50.66%), their schools had been the source of the information; 101 (66.45%) did not know how they could be infected by the virus. Age variation did not influence their knowledge on how to prevent themselves from HPV (p = 0.2562). The variable vaccine is associated with HPV prevention (p < 0.0001).

Conclusion The pregnant adolescents composing the sample have shown to have knowledge about HPV. However, they do not prevent themselves from it appropriately, given that little more than half of the sample was vaccinated, had not reported an understanding that the use of preservatives and vaccination are effective means of prevention, and did not correlate HPV with uterine cervical cancer.

Resumo

Objetivo Avaliar o nível de informação que as adolescentes gestantes possuem em relação ao papilomavírus humano (HPV).

Métodos Estudo descritivo desenvolvido no ambulatório pré-natal adolescente de um hospital terciário do estado de São Paulo, Brasil. Os dados foram coletados entre junho e dezembro de 2017, após a aprovação do comitê de ética e pesquisa (CAAE: 1.887.892/2017). A amostra foi composta por adolescentes gestantes com ≤ 18 anos que frequentaram o ambulatório. Foram excluídas as com transtorno psiquiátrico diagnosticado e as portadoras de deficiência auditiva ou de cognição. Após aceitarem participar do presente estudo, as adolescentes grávidas assinaram o termo de assentimento e consentimento livre e esclarecido. Para as análises estatísticas, foram utilizados os testes de qui-quadrado e exato de Fisher.

Resultados Em relação ao conhecimento sobre o HPV, 123 (80,92%) já tinham ouvido falar sobre o assunto; destas adolescentes, 77 (50,66%) receberam as informações que tinham através de suas escolas, e 101 (66,45%) pacientes não sabiam como poderiam contrair o vírus. A variação da idade das adolescentes entrevistadas não influenciou se estas sabiam ou não como se prevenir contra o HPV (p = 0,2562). A variável vacina está associada à prevenção contra o HPV (p < 0,0001).

Conclusão As gestantes avaliadas possuem conhecimento sobre o HPV, mas não fazem a prevenção adequada, visto que um pouco mais da metade se vacinaram, não relataram o preservativo e a vacina como métodos eficazes de prevenção, e não relacionaram o HPV com o câncer de colo de útero.

Contributors

Tanaka E. Z., Kamizaki S. S., Quintana S. M., Pacagnella R. C. and Surita F. G. contributed with the project and data interpretation, the writing of the article, the critical review of the intellectual content, and with the final approval of the version to be published.


 
  • References

  • 1 Freitas WR, Fedrizzi EM, Aguiar FG. Knowledge among college students and employees of local health units about human papillomavirus and cervical cancer and its implications for public health strategies and vaccination. DST J Bras Doenças Sex Transm. 2015; 27: 40-44 . Doi: 10.5533/DST-2177-8264-2015271-208
  • 2 Salcedo MMBP, Damin AP, Agnes G. , et al. Prevalence of human papillomavirus infection in pregnant versus non-pregnant women in Brazil. Arch Gynecol Obstet 2015; 292 (06) 1273-1278 . Doi: 10.1007/s00404-015-3752-8
  • 3 Silva EP, Vietta GG, Golfetto L. , et al. Frequency and genotyping of human papillomavirus in women submitted to citology. DST J Bras Doenças Sex Transm. 2015; 27: 22-28 . Doi: 10.5533/DST-2177-8264-2015271-205
  • 4 Medeiros LR, Ethur ABM, Hilgert JB. , et al. Vertical transmission of the human papillomavirus: a systematic quantitative review. Cad Saude Publica 2005; 21 (04) 1006-1015 . Doi: 10.1590/S0102-311 × 2005000400003
  • 5 Pirtea L, Grigoraş D, Matusz P. , et al. Human papilloma virus persistence after cone excision in women with cervical high grade squamous intraepithelial lesion: a prospective study. Can J Infect Dis Med Microbiol 2016; 2016: 3076380 . Doi: 10.1155/2016/3076380
  • 6 Burchell AN, Winer RL, de Sanjosé S, Franco EL. Chapter 6: Epidemiology and transmission dynamics of genital HPV infection. Vaccine 2006; 24 (Suppl. 03) S3 , 52–61. Doi: 10.1016/j.vaccine.2006.05.031
  • 7 Etchebehere RM, Almeida ECS, Côbo EC, Duque ACR. Murta EFC, Adad SJ. Comparison of classical and secondary cytologic criteria for diagnosing human papillomavirus. Rev Bras Ginecol Obstet 2016; 38: 41-46 . Doi: 10.1055/s-0035-1570105
  • 8 Teixeira LO, Amaral SC, Finger-Jardim F. , et al. [Frequency of Human Papillomavirus in the placenta, in the colostrum and in the umbilical cord blood]. Rev Bras Ginecol Obstet 2015; 37 (05) 203-207 . Doi: 10.1590/SO100-720320150005293
  • 9 Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Básica. Controle dos Cânceres do Colo do Útero e da Mama. 2nd ed. Brasília, DF: Ministério da Saúde; 2013
  • 10 Pizzol D, Putoto G, Chhaganlal KD. Human papillomavirus (HPV) infection: a Mozambique overview. Virusdisease 2016; 27 (02) 116-122 . Doi: 10.1007/s13337-016-0319-7
  • 11 Mehta CR, Patel NR. A network algorithm for performing Fisher's exact test in r x c contingency tables. J Am Stat Assoc 1983; 78: 427-434 . Doi: 10.1080/01621459.1983.10477989
  • 12 Ceccato Junior Benito Pio Vitorio, Guimarães Mark Drew Crosland, Lopes Ana Paula Ceccato, Nascimento Lorena Fiorini, Novaes Luísa Magalhães, Castillo Dora Méndez del et al . Incidence of Cervical Human Papillomavirus and Cervical Intraepithelial Neoplasia in Women with Positive and Negative HIV Status. Rev. Bras. Ginecol. Obstet. [Internet]. 2016 May [cited 2019 Apr 24]; 38(5): 231–238. Available from: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032016000500231&lng=en. http://dx.doi.org/10.1055/s-0036-1583294.
  • 13 Osis MJD, Duarte GA, Sousa MH. [SUS users' knowledge of and attitude to HPV virus and vaccines available in Brazil]. Rev Saude Publica 2014; 48 (01) 123-133 . Doi: 10.1590/S0034-8910.2014048005026
  • 14 Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância das Doenças Transmissíveis. Nota Informativa N° 149: Informa as Mudanças no Calendário Nacional de Vacinação para o ano de 2016. Brasília, DF: Ministério da Saúde; 2015 https://www.cvpvacinas.com.br/pdf/nota_informativa_149.pdf . Acessado Janeiro 12, 2018.
  • 15 Pereira RGV, Machado VMP, Mutran TJ, Santos LS, Machado JLM. Avaliando o conhecimento sobre o papilomavírus humano (HPV) e sua vacina. States Health 2015; 6: 135-143
  • 16 McLean HQ, VanWormer JJ, Chow BDW. , et al. Improving human papillomavirus vaccine use in an integrated health system: impact of a provider and staff intervention. J Adolesc Health 2017; 61 (02) 252-258 . Doi: 10.1016/j.jadohealth.2017.02.019
  • 17 Manoel AL, Rodrigues AB, Piva EZ, Warpechowski TP, Schuelter-Trevisol F. Evaluation of knowledge about the Human Papilloma Virus (HPV) and its vaccination among Community Health Agents in the municipality of Tubarão, Santa Catarina, Brazil, in 2014. Epidemiol Serv Saude 2017; 26 (02) 399-404 . Doi: 10.5123/s1679-49742017000200017
  • 18 Burlamaqui JCF, Cassanti AC, Borim GB, Damrose E, Villa LL, Silva L. Human Papillomavirus and students in Brazil: an assessment of knowledge of a common infection - preliminary report. Rev Bras Otorrinolaringol (Engl Ed) 2017; 83 (02) 120-125 . Doi: 10.1016/j.bjorl.2016.02.006
  • 19 Souza SV, Ponte KMA, Araújo DG. Prevenção do HPV nas mulheres: estratégia adotada por enfermeiros na atenção primária. Sanare. 2015; 14: 46-51
  • 20 Tsuchiya CT, Lawrence T, Klen MS, Fernandes RA, Alves MR. O câncer de colo do útero no Brasil: uma retrospectiva sobre as políticas públicas voltadas à saúde da mulher. J Bras Econ Saúde. 2017; 9: 137-147 . Doi: 10.21115/JBES.v9.n1.p137-47
  • 21 Chehuen Neto JA, Braga NAC, Campos JD. , et al. Atitudes dos pais diante da vacinação contra HPV na prevenção do câncer de colo do útero. Cad Saude Colet 2016; 24: 248-251 . Doi: 10.1590/1414-462 × 201600020275